Capital Investment Advisory Services LLC Has $201,000 Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Capital Investment Advisory Services LLC reduced its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 19.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,598 shares of the company’s stock after selling 624 shares during the quarter. Capital Investment Advisory Services LLC’s holdings in GE HealthCare Technologies were worth $201,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the stock. Vanguard Group Inc. grew its position in shares of GE HealthCare Technologies by 14.7% during the 3rd quarter. Vanguard Group Inc. now owns 44,531,402 shares of the company’s stock worth $3,029,917,000 after buying an additional 5,693,244 shares during the period. Invesco Ltd. grew its position in shares of GE HealthCare Technologies by 21.4% during the 3rd quarter. Invesco Ltd. now owns 5,048,262 shares of the company’s stock worth $343,484,000 after buying an additional 889,297 shares during the period. Bank of New York Mellon Corp grew its position in shares of GE HealthCare Technologies by 7.8% during the 3rd quarter. Bank of New York Mellon Corp now owns 4,380,408 shares of the company’s stock worth $298,043,000 after buying an additional 315,808 shares during the period. Northern Trust Corp grew its position in shares of GE HealthCare Technologies by 8.9% during the 3rd quarter. Northern Trust Corp now owns 4,205,506 shares of the company’s stock worth $286,143,000 after buying an additional 342,040 shares during the period. Finally, Gates Capital Management Inc. lifted its holdings in shares of GE HealthCare Technologies by 17.5% during the 3rd quarter. Gates Capital Management Inc. now owns 2,708,835 shares of the company’s stock valued at $184,309,000 after purchasing an additional 402,900 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Trading Up 0.6 %

NASDAQ GEHC opened at $86.72 on Thursday. GE HealthCare Technologies Inc. has a 52 week low of $62.35 and a 52 week high of $94.50. The stock has a market capitalization of $39.57 billion, a price-to-earnings ratio of 28.72, a PEG ratio of 3.00 and a beta of 0.94. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.83 and a current ratio of 1.05. The stock’s 50 day moving average price is $88.91 and its two-hundred day moving average price is $78.27.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.07 by $0.11. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The company had revenue of $5.20 billion for the quarter, compared to analysts’ expectations of $5.09 billion. During the same quarter in the prior year, the business posted $1.31 EPS. The business’s revenue was up 5.3% compared to the same quarter last year. As a group, analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be issued a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. The ex-dividend date of this dividend is Thursday, April 18th. GE HealthCare Technologies’s payout ratio is presently 3.97%.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on GEHC shares. HSBC started coverage on GE HealthCare Technologies in a report on Thursday, February 15th. They set a “buy” rating and a $100.00 price objective on the stock. Argus lifted their price objective on GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a report on Monday, April 1st. Mizuho lifted their price objective on GE HealthCare Technologies from $96.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, April 11th. Citigroup lifted their price objective on GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. Finally, Morgan Stanley lifted their price objective on GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a report on Monday, February 12th. Four analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and a consensus price target of $95.09.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.